Although further investigation across subtypes is required to definitively establish if somatic NLRC5 mutations are limited to aggressive lymphomas, the lack of somatic mutations in FL that we observed suggests this is not a major mechanism of MHC‐I‐mediated immune evasion in indolent lymphoma. The gene discussed is NLRC5; the disease is lymphoma.